Ogawa Tomoya, Kajiya Mikihito, Horikoshi Susumu, Yoshii Hiroki, Yoshino Mai, Motoike Souta, Morimoto Shin, Sone Hisakatsu, Iwata Tomoyuki, Ouhara Kazuhisa, Matsuda Shinji, Mizuno Noriyoshi
Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Regen Ther. 2022 Apr 28;20:117-125. doi: 10.1016/j.reth.2022.04.003. eCollection 2022 Jun.
Three-dimensional (3D) clumps of mesenchymal stem cells (MSCs)/extracellular matrix (ECM) complexes, composed with cells and self-produced intact ECM, can be grafted into defect areas without artificial scaffold to induce successful bone regeneration. Moreover, C-MSCs pretreated with IFN-γ (C-MSCsγ) increased the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) expression and thereby inhibited T cell activity. Xenotransplantation of human C-MSCsγ suppressed host T cell immune rejection and induced bone regeneration in mice. Besides, we have also reported that C-MSCs retain the 3D structure and bone regenerative property even after cryopreservation. To develop the "off-the-shelf" cell preparation for bone regenerative therapy that is promptly provided when needed, we investigated whether C-MSCsγ can retain the immunosuppressive and osteogenic properties after cryopreservation.
Confluent human MSCs that had formed on the cellular sheet were scratched using a micropipette tip and then torn off. The sheet was rolled to make a round clump of cells. The round cell clumps were incubated with a growth medium for 3 days, and then C-MSCs were obtained. To generate C-MSCsγ, after 2 days' culture, C-MSCs were stimulated with 50 ng/ml of IFN-γ. Both C-MSCs and C-MSCsγ were cryopreserved for 2 days and then thawed to obtain Cryo-C-MSCs and Cryo-C-MSCsγ, respectively. The biological properties of those cell clumps were assessed . In addition, to test whether human Cryo-C-MSCsγ attenuates immune rejection to induce bone regeneration, a xenograft study using a rat calvarial defect was performed.
Both IFN-γ pretreatment and cryopreservation process did not affect the 3D structure and cell viability in all human cell clumps. Interestingly, Cryo-C-MSCsγ showed significantly increased IDO mRNA expression equivalent to C-MSCsγ. More importantly, xenotransplantation of human C-MSCsγ and Cryo-C-MSCsγ induced rat calvarial bone regeneration by suppressing rat T cells infiltration and the grafted human cells reduction in the grafted area. Finally, there were no human donor cells in the newly formed bone, implying that the bone reconstruction by C-MSCsγ and Cryo-C-MSCsγ can be due to indirect host osteogenesis.
These findings implied that Cryo-C-MSCsγ can be a promising bone regenerative allograft therapy that can be certainly and promptly supplied on demand.
间充质干细胞(MSCs)/细胞外基质(ECM)复合物的三维(3D)团块由细胞和自身产生的完整ECM组成,可在无人工支架的情况下移植到缺损区域以诱导成功的骨再生。此外,用干扰素-γ(IFN-γ)预处理的C-MSCs(C-MSCsγ)增加了免疫调节酶吲哚胺2,3-双加氧酶(IDO)的表达,从而抑制T细胞活性。人C-MSCsγ的异种移植抑制了宿主T细胞免疫排斥反应并诱导了小鼠的骨再生。此外,我们还报道了C-MSCs即使在冷冻保存后仍保留3D结构和骨再生特性。为了开发在需要时能迅速提供的用于骨再生治疗的“现货”细胞制剂,我们研究了C-MSCsγ在冷冻保存后是否能保留免疫抑制和成骨特性。
使用微量移液器吸头刮擦在细胞片上形成的汇合的人MSCs,然后撕下。将该片卷起制成圆形细胞团块。将圆形细胞团块与生长培养基孵育3天,然后获得C-MSCs。为了生成C-MSCsγ,在培养2天后,用50 ng/ml的IFN-γ刺激C-MSCs。将C-MSCs和C-MSCsγ都冷冻保存2天,然后解冻分别获得冷冻保存的C-MSCs(Cryo-C-MSCs)和冷冻保存的C-MSCsγ(Cryo-C-MSCsγ)。评估这些细胞团块的生物学特性。此外,为了测试人冷冻保存的C-MSCsγ是否能减轻免疫排斥以诱导骨再生,进行了一项使用大鼠颅骨缺损的异种移植研究。
IFN-γ预处理和冷冻保存过程均未影响所有人细胞团块的3D结构和细胞活力。有趣的是,冷冻保存的C-MSCsγ显示出与C-MSCsγ相当的IDO mRNA表达显著增加。更重要的是,人C-MSCsγ和冷冻保存的C-MSCsγ的异种移植通过抑制大鼠T细胞浸润和移植区域内移植的人细胞减少而诱导了大鼠颅骨骨再生。最后,在新形成的骨中没有人类供体细胞,这意味着C-MSCsγ和冷冻保存的C-MSCsγ的骨重建可能是由于间接的宿主骨生成。
这些发现表明,冷冻保存的C-MSCsγ可能是一种有前景的骨再生同种异体移植疗法,能够根据需要确定且迅速地提供。